Sales rise 87.11% to Rs 28.44 crore
Net profit of Bafna Pharmaceuticals rose 395.83% to Rs 2.38 crore in the quarter ended September 2021 as against Rs 0.48 crore during the previous quarter ended September 2020. Sales rose 87.11% to Rs 28.44 crore in the quarter ended September 2021 as against Rs 15.20 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales28.4415.20 87 OPM %20.048.42 -PBDT5.771.49 287 PBT4.350.48 806 NP2.380.48 396Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content